The ACR Government Affairs Committee has developed legislative language to limit commercial insurance plans’ cost-sharing requirements for medications in a specialty drug tier to the dollar amount applicable to drugs in the nonpreferred-brand drug tier.
Managing an In-Office Infusion Practice
The increased utilization of infusible biologics for the treatment of rheumatic diseases has opened the door for you to provide more integrated care for your patients. Having an in-office infusion center gives you the ability to deliver this service to your patients in a familiar and supportive setting.
Drug Updates: EULAR 2012
Tracking the results of drug safety and efficacy
California Rheumatologists Explore Managed Care, Treatment Options
Advances in SLE, osteoporosis, and RA highlighted at California Rheumatology Alliance meeting.
Drug Updates
Information on new approvals and medication safety.
ACR Issues Guidelines, Recommendations for Lupus Nephritis, RA
Detailed screening and treatment recommendations based on current evidence, extensive literature review.
Clinical Opportunities at the 2012 ACR/ARHP Annual Meeting
The Annual Meeting will provide numerous opportunities to learn the latest clinical findings in the field and to update their knowledge in all aspects of rheumatology.
Medication Quick Guides Offer Infusion Staff a Streamlined Resource
The ACR/ARHP Medication Quick Guides offer easily accessable pharmaceutical information to rheumatologists.
10 Tips for Better Communication in Rheumatology
Bring clarity to your interactions with patients, staff, and colleagues.
Drug Updates: Citalopram hydrobromide, Statins, and More
Information on new approvals and medication safety
- « Previous Page
- 1
- …
- 9
- 10
- 11
- 12
- 13
- Next Page »